Bicocca Open Archive

Logo unimib boa
BALDUZZI, ADRIANA CRISTINA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 15.715
AS - Asia 11.709
EU - Europa 7.537
SA - Sud America 1.862
AF - Africa 304
OC - Oceania 48
Continente sconosciuto - Info sul continente non disponibili 8
Totale 37.183
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 15.061
SG - Singapore 3.926
VN - Vietnam 2.379
CN - Cina 2.031
IT - Italia 1.624
HK - Hong Kong 1.535
RU - Federazione Russa 1.530
BR - Brasile 1.381
DE - Germania 841
IE - Irlanda 754
SE - Svezia 747
CA - Canada 454
FR - Francia 382
IN - India 371
GB - Regno Unito 364
UA - Ucraina 313
FI - Finlandia 232
BD - Bangladesh 207
ID - Indonesia 188
AR - Argentina 169
KR - Corea 158
TR - Turchia 149
ES - Italia 139
JP - Giappone 129
MX - Messico 121
IQ - Iraq 111
NL - Olanda 106
PL - Polonia 97
ZA - Sudafrica 94
AT - Austria 85
EC - Ecuador 80
PK - Pakistan 73
PH - Filippine 70
CO - Colombia 56
BE - Belgio 48
SA - Arabia Saudita 48
VE - Venezuela 47
CL - Cile 43
AU - Australia 39
UZ - Uzbekistan 39
LT - Lituania 38
CH - Svizzera 36
CZ - Repubblica Ceca 35
IR - Iran 35
MA - Marocco 32
EG - Egitto 31
PY - Paraguay 31
IL - Israele 30
GR - Grecia 29
DK - Danimarca 28
JO - Giordania 28
KE - Kenya 28
AE - Emirati Arabi Uniti 27
ET - Etiopia 24
TN - Tunisia 24
MY - Malesia 23
NP - Nepal 21
UY - Uruguay 21
PE - Perù 20
TW - Taiwan 20
PT - Portogallo 19
KZ - Kazakistan 15
TH - Thailandia 14
BG - Bulgaria 13
DO - Repubblica Dominicana 13
DZ - Algeria 13
OM - Oman 13
PA - Panama 13
AZ - Azerbaigian 12
BO - Bolivia 11
JM - Giamaica 11
NG - Nigeria 11
RO - Romania 11
AL - Albania 10
CR - Costa Rica 10
RS - Serbia 10
SK - Slovacchia (Repubblica Slovacca) 10
SN - Senegal 10
NZ - Nuova Zelanda 9
HN - Honduras 8
AO - Angola 7
BH - Bahrain 7
LA - Repubblica Popolare Democratica del Laos 7
LB - Libano 7
PS - Palestinian Territory 7
TT - Trinidad e Tobago 7
NI - Nicaragua 6
NO - Norvegia 6
LV - Lettonia 5
LY - Libia 5
MU - Mauritius 5
BA - Bosnia-Erzegovina 4
EU - Europa 4
GT - Guatemala 4
HR - Croazia 4
HU - Ungheria 4
KG - Kirghizistan 4
QA - Qatar 4
SI - Slovenia 4
SV - El Salvador 4
Totale 37.123
Salva come PNG Salva come JPEG
Città #
Ann Arbor 2.176
Singapore 2.082
Hong Kong 1.500
Ashburn 1.431
Fairfield 1.012
San Jose 971
Woodbridge 810
Dublin 733
Ho Chi Minh City 724
Hanoi 597
Wilmington 595
Chandler 524
Houston 497
Frankfurt am Main 464
Seattle 450
Milan 447
New York 424
Dallas 395
Santa Clara 375
Los Angeles 333
Chicago 331
Hefei 324
Cambridge 288
Dearborn 286
Toronto 281
Beijing 270
Jacksonville 263
Princeton 232
The Dalles 197
Lauterbourg 168
Moscow 164
Seoul 146
São Paulo 145
Jakarta 131
Council Bluffs 118
Shanghai 114
Helsinki 113
Lawrence 113
Buffalo 112
Nanjing 96
Altamura 92
Rome 84
Munich 82
Da Nang 77
San Diego 75
Tokyo 72
Haiphong 71
Orem 71
Nuremberg 63
Rio de Janeiro 63
Warsaw 63
London 62
Denver 59
Montreal 55
Baghdad 51
Biên Hòa 50
Andover 47
Ha Long 47
Chennai 46
Johannesburg 46
Guangzhou 45
Atlanta 44
Dhaka 42
Lappeenranta 41
Salt Lake City 40
Quận Bình Thạnh 39
Turku 39
Dong Ket 37
Tashkent 37
Fremont 36
Lachine 36
Phoenix 36
Mexico City 35
Boardman 34
Hải Dương 34
Naples 34
Poplar 34
Vienna 34
Brooklyn 33
Brussels 33
Changsha 33
Kent 33
Nanchang 33
New Delhi 33
Istanbul 32
Lissone 32
Paris 32
Ankara 31
Stockholm 31
Tianjin 31
Turin 31
Amsterdam 28
Can Tho 28
Thái Nguyên 28
Quận Một 27
Belo Horizonte 26
Boston 26
Buenos Aires 26
Hangzhou 26
Quito 26
Totale 23.044
Salva come PNG Salva come JPEG
Nome #
ABO incompatibile graft management in pediatric transplantation 689
Hormonal replacement therapy in adolescents and young women with chemo- or radio-induced premature ovarian insufficiency: Practical recommendations 527
Treatment of Graft versus Host Disease with Mesenchymal Stromal Cells: A Phase I Study on 40 Adult and Pediatric Patients 478
Busulfan–fludarabine- or treosulfan–fludarabine-based conditioning before allogeneic HSCT from matched sibling donors in paediatric patients with sickle cell disease: A study on behalf of the EBMT Paediatric Diseases and Inborn Errors Working Parties 473
Long-term complications after allogeneic hematopoietic stem cell transplantation for pediatric patients with acute leukemia or myelodysplastic syndrome given either a Treosulfan- or a Busulfan-based conditioning regimen: results of an AIEOP (Associazione Italiana Ematologia Oncologia Pediatrica) retrospective study 464
Phase II Study of Sequential Infusion of Donor Lymphocyte Infusion and Cytokine-Induced Killer Cells for Patients Relapsed after Allogeneic Hematopoietic Stem Cell Transplantation 464
Cardiofaciocutaneous syndrome and immunodeficiency: data from an international multicenter cohort 433
Sleeping Beauty-engineered CAR T cells achieve anti-leukemic activity without severe toxicities 427
Avascular necrosis of the talus in pediatric acute lymphoblastic leukemia: Current concepts 416
Pentraxin 3 plasma levels at graft-versus-host disease onset predict disease severity and response to therapy in children given haematopoietic stem cell transplantation 400
Combined CAR-T/HSCT approach in a patient with refractory acute lymphoblastic leukemia and cystic fibrosis 391
Mesenchymal stromal cells for the treatment of graft-versus-host disease: understanding the in vivo biological effect through patient immune monitoring 378
Fertility preservation issues in pediatric hematopoietic stem cell transplantation: Practical approaches from the consensus of the Pediatric Diseases Working Party of the EBMT and the International BFM Study Group 374
Interleukin-17-producing t-helper cells as new potential player mediating graft-versus-host disease in patients undergoing allogeneic stem-cell transplantation 356
Safe and Effective Treatment of Graft Versus Host Disease with Platelet Lysate-Expanded Human Mesenchymal Stromal Cells: A Phase 1 Study On 47 Adult and Pediatric Patients 345
T cells stimulated by CD40L positive leukemic blasts-pulsed dendritic cells meet optimal functional requirements for adoptive T-cell therapy 339
Children with cancer in the time of COVID-19: An 8-week report from the six pediatric onco-hematology centers in Lombardia, Italy 339
Immune effector cell–associated hematotoxicity: EHA/EBMT consensus grading and best practice recommendations 335
Regulatory T cells and extracorporeal photochemotherapy: correlation with clinical response and decreased frequency of proinflammatory T cells. 330
Platelet-lysate-expanded mesenchymal stromal cells as a salvage therapy for severe resistant graft-versus-host disease in a pediatric population 327
Hepatic focal nodular hyperplasia after pediatric hematopoietic stem cell transplantation: The impact of hormonal replacement therapy and iron overload 319
Mesenchymal stromal cells do not increase the risk of viral reactivation nor the severity of viral events in recipients of allogeneic stem cell transplantation 308
Lessons after the early management of the COVID-19 outbreak in a pediatric transplant and hemato-oncology center embedded within a COVID-19 dedicated hospital in Lombardia, Italy. Estote parati 308
CD34(+) stem cell recovery after positive selection of "overloaded" immunomagnetic columns 304
Autologous Purified Peripheral Blood Stem Cell Transplantation Compare to Chemotherapy in Childhood Acute Lymphoblastic Leukemia after Low-Risk Relapse 303
State-of-the-art fertility preservation in children and adolescents undergoing haematopoietic stem cell transplantation: a report on the expert meeting of the Paediatric Diseases Working Party (PDWP) of the European Society for Blood and Marrow Transplantation (EBMT) in Baden, Austria, 29-30 September 2015 299
Pediatric immune myelofibrosis (PedIMF) as a novel and distinct clinical pathological entity 297
High EVI1 Expression due to NRIP1/EVI1 Fusion in Therapy-related Acute Myeloid Leukemia: Description of the First Pediatric Case 292
Thyroid disorders following hematopoietic stem cell transplantation in childhood: the impact of the conditioning regimen on thyroid dysfunction, volume changes and occurrence of nodules 289
A novel homozygous disruptive PRF1 variant (K285Sfs*4) causes very early-onset of familial hemophagocytic lymphohystiocytosis type 2 288
Bath PUVA therapy in pediatric patients with drug-resistant cutaneous graft-versus-host disease 279
Extracorporeal photochemotherapy is accompanied by increasing levels of circulating CD4+CD25+GITR+Foxp3+CD62L+ functional regulatory T-cells in patients with graft-versus-host disease. 278
Thyroid function disorders and secondary cancer following haematopoietic stem cell transplantation in pediatrics: State of the art and practical recommendations for a risk-based follow-up 273
Donor-derived CARCIK-CD19 cells engineered with Sleeping Beauty transposon in acute lymphoblastic leukemia relapsed after allogeneic transplantation 270
Minimal residual disease before and after transplantation for childhood acute lymphoblastic leukaemia: is there any room for intervention? 267
Polyomavirus JC-targeted T-cell therapy for progressive multiple leukoencephalopathy in a hematopoietic cell transplantation recipient 263
Precision-based exercise as a new therapeutic option for children and adolescents with haematological malignancies 257
Iron Overload Following Hematopoietic Stem Cell Transplantation: Prevalence, Severity, and Management in Children and Adolescents with Malignant and Nonmalignant Diseases 255
Long-term effects of bone marrow transplantation on dental status in children with leukaemia 255
Pubertal attainment and Leydig cell function following pediatric hematopoietic stem cell transplantation: a three-decade longitudinal assessment 254
Transplantation in Children and Adolescents with Acute Lymphoblastic Leukemia from a Matched Donor versus an HLA-Identical Sibling: Is the Outcome Comparable? Results from the International BFM ALL SCT 2007 Study 254
PENTRAXIN 3 PLASMA LEVELS AT GRAFT-VERSUS-HOST DISEASE ONSET PREDICT DISEASE SEVERITY AND RESPONSE TO THERAPY IN CHILDREN GIVEN HEMATOPOIETIC STEM CELL TRANSPLANTATION 252
Germ-Line TP53 Mutation in an Adolescent With CMML/Atypical CML and Familiar Cancer Predisposition 250
TBI, etoposide and cyclophosphamide as a promising conditioning regimen for BMT in childhood ALL in second remission 248
Safety and efficacy of narsoplimab in pediatric and adult patients with transplant-associated thrombotic microangiopathy: a real-world experience 247
When to suspect GATA2 deficiency in pediatric patients: from complete blood count to diagnosis 245
Endocrine, auxological and metabolic profile in children and adolescents with Down syndrome: from infancy to the first steps into adult life 242
Pentraxin-3 Increases At The Onset Of Graft-Versus-Host Disease In Transplanted Patients 236
Total Body Irradiation or Chemotherapy Conditioning in Childhood ALL: A Multinational, Randomized, Noninferiority Phase III Study 235
Donor selection in Adults and Pediatrics 234
Impact of marrow unrelated donor search duration on outcome of children with acute lymphoblastic leukemia in second remission 232
Febrile complications in the first 100 days after bone marrow transplantation in children: a single center's experience 231
Tisagenlecleucel in Children and Young Adults with B-Cell Lymphoblastic Leukemia 231
Response to rituximab-based therapy and risk factor analysis in epstein barr virus-related lymphoproliferative disorder after hematopoietic stem cell transplant in children and adults: A study from the infectious diseases working party of the european group for blood and marrow transplantation 229
Carcik-CD19 Cells Expand In Vivo Toward a CD8+ Memory Phenotype and Their Persistence Is Associated with a Longer Duration of Response 228
Case Report: Successful use of emapalumab in adult B-cell acute lymphoblastic leukemia experiencing severe neurotoxicity and hemophagocytic lymphohistiocytosis-like features after CAR-T cell therapy 226
Red blood cell support and alloimmunization rate against erythrocyte antigens in patients undergoing hematopoietic stem cell transplantation 223
Transplant-related toxicity and mortality: An AIEOP prospective study in 636 pediatric patients transplanted for acute leukemia 221
Flash survey on severe acute respiratory syndrome coronavirus-2 infections in paediatric patients on anticancer treatment 221
Isolated leukopenia in children and adolescents referred to a Pediatric Hematology Clinic 218
Pelvic ultrasound and pubertal attainment in girls with sexual precocity: the pivotal role of uterine volume in predicting the timing of menarche 217
Extracorporeal photochemotherapy for the treatment of chronic graft-versus-host disease: trend for a possible cell dose-related effect? 217
The impact of MRD in HCT for childhood ALL 215
aGvHDtrackR and cGvHDtrackR: shiny applications for graft versus host disease management and clinical data collection 211
Chronic graft-versus-host disease in children: incidence, risk factors, and impact on outcome 211
The role of haematopoietic stem cell transplantation for sickle cell disease in the era of targeted disease-modifying therapies and gene editing 211
First-Line Postremission Blinatumomab as Successful Toxicity-Sparing Strategy in a Boy with Cystic Fibrosis and Acute Lymphoblastic Leukemia 209
Prospective study on allogeneic bone marrow transplantation (allo BMT) versus chemotherapy (chemo) for very high-risk (vhr) childhood acute lymphoblastic leukaemia in first complete remission 209
Eligibility for allogeneic transplantation in very high risk childhood acute lymphoblastic leukemia: The impact of the waiting time 209
Chemotherapy versus allogeneic transplantation for very-high-risk childhood acute lymphoblastic leukaemia in first complete remission: Comparison by genetic randomisation in an international prospective study 208
Osteonecrosis in paediatric acute lymphoblastic leukaemia: Incidence, risk factors, radiological patterns and evolution in a single-centre cohort 205
The impact of donor type on the outcome of pediatric patients with very high risk acute lymphoblastic leukemia. A study of the ALL SCT 2003 BFM-SG and 2007-BFM-International SG 203
Reconstitution of lymphocyte subpopulations in children with inherited metabolic storage diseases after haematopoietic cell transplantation 200
Childhood cancer in Italy: background, goals, and achievements of the Italian Paediatric Hematology Oncology Association (AIEOP) 200
Moebius syndrome and hypopituitarism: a case of multiple pituitary hormone deficiency and revision of the literature 199
Allogeneic bone marrow transplantation versus chemotherapy in high-risk childhood acute lymphoblastic leukaemia in first remission 198
Mechanical and infective central venous catheter-related complications: a prospective non-randomized study using Hickman and Groshong catheters in children with hematological malignancies 198
Transplantation in childhood very high risk acute lymphoblastic leukemia in first complete remission: where are we now? 196
Impact of thrombotic thrombocytopenic purpura on leukemic children undergoing bone marrow transplantation 196
Serum anti-Müllerian hormone as a marker of ovarian reserve after cancer treatment and/or hematopoietic stem cell transplantation in childhood: proposal for a systematic approach to gonadal assessment 195
Allogeneic Stem Cell Transplantation from HLA-Mismatched Donors for Pediatric Patients with Acute Lymphoblastic Leukemia Treated According to the 2003 BFM and 2007 International BFM Studies: Impact of Disease Risk on Outcomes 194
A novel flow-cytometric based method to assess post-HSCT donor chimerism exploiting RNA hybridization 193
A persistent severe autoimmune hemolytic anemia despite apparent direct antiglobulin test negativization 193
Purified autologous grafting in childhood acute lymphoblastic leukemia in second remission: evidence for long-term clinical and molecular remissions 192
Management of ovarian granulosa cell tumor in childhood: a case report and recommendations for a multidisciplinary approach 191
Front-line imatinib treatment in children and adolescents with chronic myeloid leukemia: Results from a phase III trial 191
Autologous purified peripheral blood SCT in childhood low-risk relapsed ALL 191
Successful sequential liver and hematopoietic stem cell transplantation in a patient with Fanconi anemia 187
Supportive care during pediatric hematopoietic stem cell transplantation: beyond infectious diseases. A report from workshops on supportive care of the Pediatric Diseases Working Party (PDWP) of the European Society for Blood and Marrow Transplantation (EBMT) 186
Tetralogy of Fallot with absent pulmonary valve: definitive diagnosis by two-dimensional echocardiography 185
Diagnosis and severity criteria for sinusoidal obstruction syndrome/veno-occlusive disease in pediatric patients: A new classification from the European society for blood and marrow transplantation 185
Outcome of children relapsing after first allogeneic haematopoietic stem cell transplantation for acute myeloid leukaemia: a retrospective I-BFM analysis of 333 children 184
Late Adverse Events Following Stem Cell Transplantation in Childhood Acute Lymphoblastic Leukaemia: State of the Art 182
Long-Term Host Immune Modulation Following Tisagenlecleucel Administration in Patients with Diffuse Large B-Cell Lymphoma and B-Lineage Acute Lymphoblastic Leukemia 182
COVID-19 in Immunosuppressed Children 180
Osteopathic treatment and evaluation in the clinical setting of childhood hematological malignancies 180
Two pregnancies shortly after transplantation with reduced intensity conditioning in chronic myeloid leukemia 178
More precisely defining risk peri-HCT in pediatric ALL: Pre- vs post-MRD measures, serial positivity, and risk modeling 178
Effectiveness of extracorporeal photochemotherapy in treating long-term refractory chronic graft-versus-host disease 176
The Impact of a Precision-Based Exercise Intervention in Childhood Hematological Malignancies Evaluated by an Adapted Yo-Yo Intermittent Recovery Test 175
Totale 26.456
Salva come PNG Salva come JPEG
Categoria #
all - tutte 118.925
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 118.925
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021455 0 0 0 0 0 0 0 0 0 0 190 265
2021/20221.750 158 231 229 159 78 113 74 86 129 122 130 241
2022/20232.682 318 716 163 186 225 418 53 195 217 25 92 74
2023/20242.385 77 69 133 123 300 544 458 88 238 54 77 224
2024/20256.752 345 882 361 307 455 259 311 244 674 862 752 1.300
2025/202616.795 2.332 1.384 1.289 2.015 1.790 833 2.270 774 1.805 1.719 584 0
Totale 38.157